Authors:
Messele, T
Brouwer, M
Girma, M
Fontanet, AL
Miedema, F
Hamann, D
de Wit, TFR
Citation: T. Messele et al., Plasma levels of viro-immunological markers in HIV-infected and noninfected ethiopians: Correlation with cell surface activation markers, CLIN IMMUNO, 98(2), 2001, pp. 212-219
Authors:
Hazenberg, MD
Verschuren, MCM
Hamann, D
Miedema, F
van Dongen, JJM
Citation: Md. Hazenberg et al., T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation, J MOL MED-J, 79(11), 2001, pp. 631-640
Authors:
Van Praag, RME
Prins, JM
Roos, MTL
Schellekens, PTA
Ten Berge, IJM
Yong, SL
Schuitemaker, H
Eerenberg, AJM
Jurriaans, S
De Wolf, F
Fox, CH
Goudsmit, J
Miedema, F
Lange, JMA
Citation: Rme. Van Praag et al., OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion, J CLIN IMM, 21(3), 2001, pp. 218-226
Authors:
Kostense, S
Raaphorst, FM
Joling, J
Notermans, DW
Prins, JM
Danner, SA
Reiss, P
Lange, JMA
Teale, JM
Miedema, F
Citation: S. Kostense et al., T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy, AIDS, 15(9), 2001, pp. 1097-1107
Authors:
Lindenburg, CEA
Langendam, MW
Von Benthem, BHB
Miedema, F
Coutinho, RA
Citation: Cea. Lindenburg et al., No evidence that vaccination with a polysaccharide pneumococcal vaccine protects drug users against all-cause pneumonia, AIDS, 15(10), 2001, pp. 1315-1317
Authors:
Kostense, S
Ogg, GS
Manting, EH
Gillespie, G
Joling, J
Vandenberghe, K
Veenhof, EZ
van Baarle, D
Jurriaans, S
Klein, MR
Miedema, F
Citation: S. Kostense et al., High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function, EUR J IMMUN, 31(3), 2001, pp. 677-686
Authors:
van Baarle, D
Hovenkamp, E
Callan, MFC
Wolthers, KC
Kostense, S
Tan, LC
Niesters, HGM
Osterhaus, ADME
McMichael, AJ
van Oers, MHJ
Miedema, F
Citation: D. Van Baarle et al., Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-relatednon-Hodgkin lymphoma, BLOOD, 98(1), 2001, pp. 146-155
Authors:
Stuart, JWTC
Hazebergh, MD
Hamann, D
Otto, SA
Borleffs, JCC
Miedema, F
Boucher, CAB
de Boer, RJ
Citation: Jwtc. Stuart et al., The dominant source of CD4(+) and CD8(+) T-cell activation in HIV infection is antigenic stimulation, J ACQ IMM D, 25(3), 2000, pp. 203-211
Authors:
Hazenberg, MD
Otto, SA
Stuart, JWTC
Verschuren, MCM
Borleffs, JCC
Boucher, CAB
Coutinho, RA
Lange, JMA
De Wit, TFR
Tsegaye, A
Van Dongen, JJM
Hamann, D
De Boer, RJ
Miedema, F
Citation: Md. Hazenberg et al., Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection, NAT MED, 6(9), 2000, pp. 1036-1042
Authors:
Messele, T
Roos, MTL
Hamann, D
Koot, M
Fontanet, AL
Miedema, F
Schellekens, PTA
de Vit, TFR
Citation: T. Messele et al., Nonradioactive techniques for measurement of in vitro T-cell proliferation: Alternatives to the [H-3]thymidine incorporation assay, CL DIAG LAB, 7(4), 2000, pp. 687-692
Authors:
Kostense, S
Krop, E
Blaak, H
Schuitemaker, H
Miedema, F
Citation: S. Kostense et al., Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants, AIDS, 14(3), 2000, pp. 330-331
Authors:
Fleury, S
Rizzardi, GP
Chapuis, A
Tambussi, G
Knabenhans, C
Simeoni, E
Meuwly, JY
Corpataux, JM
Lazzarin, A
Miedema, F
Pantaleo, G
Citation: S. Fleury et al., Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy, P NAS US, 97(10), 2000, pp. 5393-5398
Authors:
Roos, MTL
van Lier, RAW
Hamann, D
Knol, GJ
Verhoofstad, I
van Baarle, D
Miedema, F
Schellekens, PTA
Citation: Mtl. Roos et al., Changes in the composition of circulating CD8(+) T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans, J INFEC DIS, 182(2), 2000, pp. 451-458
Authors:
van Baarle, D
Hovenkamp, E
Dukers, NHTM
Renwick, N
Kersten, MJ
Goudsmit, J
Coutinho, RA
Miedema, F
van Oers, MHJ
Citation: D. Van Baarle et al., High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission, J INFEC DIS, 181(6), 2000, pp. 2045-2049
Authors:
Clark, DR
Repping, S
Pakker, NG
Prins, JM
Notermans, DW
Wit, FWNM
Reiss, P
Danner, SA
Coutinho, RA
Lange, JMA
Miedema, F
Citation: Dr. Clark et al., T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy, BLOOD, 96(1), 2000, pp. 242-249
Authors:
Hazenberg, MD
Stuart, JWTC
Otto, SA
Borleffs, JCC
Boucher, CAB
de Boer, RJ
Miedema, F
Hamann, D
Citation: Md. Hazenberg et al., T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART), BLOOD, 95(1), 2000, pp. 249-255
Authors:
Hamann, D
Kostense, S
Wolthers, KC
Otto, SA
Baars, PA
Miedema, F
van Lier, RAW
Citation: D. Hamann et al., Evidence that human CD8(+)CD45RA(+)CD27(-) cells are induced by antigen and evolve through extensive rounds of division, INT IMMUNOL, 11(7), 1999, pp. 1027-1033
Authors:
Wolthers, KC
Noest, AJ
Otto, SA
Miedema, F
De Boer, RJ
Citation: Kc. Wolthers et al., Normal telomere lengths in naive and memory CD4(+) T cells in HIV type 1 infection: A mathematical interpretation, AIDS RES H, 15(12), 1999, pp. 1053-1062
Authors:
Pontesilli, O
Carotenuto, P
Kerkhof-Garde, SR
Roos, MTM
Keet, IPM
Coutinho, RA
Goudsmit, J
Miedema, F
Citation: O. Pontesilli et al., Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type I infection is predictive of persistent AIDS-free infection, AIDS RES H, 15(11), 1999, pp. 973-981
Authors:
Krol, A
Flynn, C
Vlahov, D
Miedema, F
Coutinho, RA
van Ameijden, EJC
Citation: A. Krol et al., New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users, DRUG AL DEP, 54(2), 1999, pp. 145-154